Life Technologies (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition.
Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better.
Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company had sales of more than $3 billion, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.
Gregory T. Lucier, Chairman and Chief Executive Officer
Mark Stevenson, President and Chief Operating Officer
David F. Hoffmeister, Chief Financial Officer
Nicolas Barthelemy, President, Cell Systems
Joe Beery, Chief Information Officer
Claude D. Benchimol, Ph.D., Senior Vice President, Research and Development, Genetic Systems
Bernd Brust, President and Chief Commercial Operations Officer
John Cottingham, Chief Legal Officer
Peter Dansky, President, Molecular Biology Systems
Paul Grossman, Ph.D., Senior Vice President, Strategy and Corporate Development
Laura Lauman, President, Mass Spectrometry
Peter Leddy, Ph.D., Senior Vice President, Global Human Resources
John “Kip” Miller, President, Genetic Systems
Mark O’Donnell, Senior Vice President, Global Operations and Services
Brian Pollok, Ph.D., Chief Scientific Officer, Head of Global Research and Development
Kelli A. Richard, Vice President, Finance and Chief Accounting Officer
Amanda Clardy, Vice President, Investor Relations and Corporate Communications